110 related articles for article (PubMed ID: 16886680)
1. Antiproliferative activity of vitamin D compounds in combination with cytostatics.
Pelczynska M; Switalska M; Maciejewska M; Jaroszewicz I; Kutner A; Opolski A
Anticancer Res; 2006; 26(4A):2701-5. PubMed ID: 16886680
[TBL] [Abstract][Full Text] [Related]
2. Correlation between VDR expression and antiproliferative activity of vitamin D3 compounds in combination with cytostatics.
Pelczynska M; Wietrzyk J; Jaroszewicz I; Nevozhay D; Switalska M; Kutner A; Zabel M; Opolski A
Anticancer Res; 2005; 25(3B):2235-40. PubMed ID: 16158969
[TBL] [Abstract][Full Text] [Related]
3. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.
Wietrzyk J; Nevozhay D; Filip B; Milczarek M; Kutner A
Anticancer Res; 2007; 27(5A):3387-98. PubMed ID: 17970085
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative activity in vitro of side-chain analogues of calcitriol against various human normal and cancer cell lines.
Opolski A; Wietrzyk J; Chrobak A; Marcinkowska E; Wojdat E; Kutner A; Radzikowski C
Anticancer Res; 1999; 19(6B):5217-22. PubMed ID: 10697538
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of the antiproliferative effect in vitro of doxorubicin, cisplatin and genistein by new analogues of vitamin D.
Siwińska A; Opolski A; Chrobak A; Wietrzyk J; Wojdat E; Kutner A; Szelejewski W; Radzikowski C
Anticancer Res; 2001; 21(3B):1925-9. PubMed ID: 11497279
[TBL] [Abstract][Full Text] [Related]
6. The effect of combined treatment on head and neck human cancer cell lines with novel analogs of calcitriol and cytostatics.
Wietrzyk J; Milczarek M; Kutner A
Oncol Res; 2007; 16(11):517-25. PubMed ID: 18306931
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition of cancer cells by an active metabolite of a novel vitamin D prodrug.
Wang YR; Wigington DP; Strugnell SA; Knutson JC
Anticancer Res; 2005; 25(6B):4333-9. PubMed ID: 16309237
[TBL] [Abstract][Full Text] [Related]
8. Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model.
Wietrzyk J; Nevozhay D; Milczarek M; Filip B; Kutner A
Cancer Chemother Pharmacol; 2008 Oct; 62(5):787-97. PubMed ID: 18188568
[TBL] [Abstract][Full Text] [Related]
9. Combination study of 1,24(S)-dihydroxyvitamin D2 and chemotherapeutic agents on human breast and prostate cancer cell lines.
Wigington DP; Urben CM; Strugnell SA; Knutson JC
Anticancer Res; 2004; 24(5A):2905-12. PubMed ID: 15517895
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D compounds: clinical development as cancer therapy and prevention agents.
Trump DL; Muindi J; Fakih M; Yu WD; Johnson CS
Anticancer Res; 2006; 26(4A):2551-6. PubMed ID: 16886663
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of Ru(III) complexes carrying beta-diketonato ligands in vitro and in vivo.
Arandjelovic SS; Bjelogrlic KS; Malesevic NN; Tesic LjZ; Radulovic SS
J BUON; 2009; 14(2):271-9. PubMed ID: 19650178
[TBL] [Abstract][Full Text] [Related]
12. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
[TBL] [Abstract][Full Text] [Related]
13. In vitro combined effect of a new series of copper (II) complexes with cisplatin or epirubicin on human breast and cervical cancer cell lines.
Geromichalos GD; Katsoulos GA; Hadjikostas CC; Kortsaris AH; Kyriakidis DA
Drugs Exp Clin Res; 1998; 24(2):93-104. PubMed ID: 9675550
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.
Maj E; Filip-Psurska B; Milczarek M; Psurski M; Kutner A; Wietrzyk J
Int J Oncol; 2018 Feb; 52(2):337-366. PubMed ID: 29345296
[TBL] [Abstract][Full Text] [Related]
15. Influence of vitamin D(3) analogues in combination with budesonid R on proliferation of nasal polyp fibroblasts.
Rostkowska-Nadolska B; Fraczek M; Gawron W; Latocha M
Acta Biochim Pol; 2009; 56(2):235-42. PubMed ID: 19503845
[TBL] [Abstract][Full Text] [Related]
16. Side-chain-modified analogs of calcitriol cause resistance of human HL-60 promyelocytic leukemia cells to drug-induced apoptosis.
Chrobak A; Radzikowski C; Opolski A
Steroids; 2005 Jan; 70(1):19-27. PubMed ID: 15610893
[TBL] [Abstract][Full Text] [Related]
17. Effects of calcitriol, seocalcitol, and medium-chain triglyceride on a canine transitional cell carcinoma cell line.
Kaewsakhorn T; Kisseberth WC; Capen CC; Hayes KA; Calverley MJ; Inpanbutr N
Anticancer Res; 2005; 25(4):2689-96. PubMed ID: 16080513
[TBL] [Abstract][Full Text] [Related]
18. Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191).
Wietrzyk J; Pełczyńska M; Madej J; Dzimira S; Kuśnierczyk H; Kutner A; Szelejewski W; Opolski A
Steroids; 2004 Sep; 69(10):629-35. PubMed ID: 15465107
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
[TBL] [Abstract][Full Text] [Related]
20. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
